Literature DB >> 29322543

Effect of eptifibatide on inflammation during acute pain episodes in sickle cell disease.

Julia E Brittain1, Ciprian Anea1, Payal Desai2, Jack Delaney3, Adam McDonald3, Stephen W Looney4, Nigel S Key3, Leslie V Parise5, Kenneth I Ataga3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29322543      PMCID： PMC5926197          DOI： 10.1002/ajh.25032

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.

Authors:  Marilyn J Telen; Ted Wun; Timothy L McCavit; Laura M De Castro; Lakshmanan Krishnamurti; Sophie Lanzkron; Lewis L Hsu; Wally R Smith; Seungshin Rhee; John L Magnani; Helen Thackray
Journal:  Blood       Date:  2015-03-02       Impact factor: 22.113

2.  Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease.

Authors:  Grace Chen; Dachuan Zhang; Tobias A Fuchs; Deepa Manwani; Denisa D Wagner; Paul S Frenette
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

3.  3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.

Authors:  S L Hazen; J W Heinecke
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

Review 4.  The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.

Authors:  Robert P Hebbel; Raymond Osarogiagbon; Dhananjay Kaul
Journal:  Microcirculation       Date:  2004-03       Impact factor: 2.628

5.  Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.

Authors:  Kenneth I Ataga; Abdullah Kutlar; Julie Kanter; Darla Liles; Rodolfo Cancado; João Friedrisch; Troy H Guthrie; Jennifer Knight-Madden; Ofelia A Alvarez; Victor R Gordeuk; Sandra Gualandro; Marina P Colella; Wally R Smith; Scott A Rollins; Jonathan W Stocker; Russell P Rother
Journal:  N Engl J Med       Date:  2016-12-03       Impact factor: 91.245

6.  A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease.

Authors:  Payal C Desai; Julia E Brittain; Susan K Jones; Adam McDonald; Douglas R Wilson; Rosalie Dominik; Nigel S Key; Leslie V Parise; Kenneth I Ataga
Journal:  Thromb Res       Date:  2013-08-08       Impact factor: 3.944
  6 in total
  2 in total

Review 1.  A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.

Authors:  Jacob Fiocchi; Ivan Urits; Vwaire Orhurhu; Mariam Salisu Orhurhu; Stephen Giacomazzi; Briggs Hoyt; Alan D Kaye; Rachel J Kaye; Omar Viswanath
Journal:  Curr Pain Headache Rep       Date:  2020-03-21

Review 2.  Emerging disease-modifying therapies for sickle cell disease.

Authors:  Marcus A Carden; Jane Little
Journal:  Haematologica       Date:  2019-08-14       Impact factor: 9.941
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.